1887

Journal of Medical Microbiology logo

Volume 61, Issue 7

Globally dispersed mobile drug-resistance genes in Gram-negative bacterial isolates from patients with bloodstream infections in a US urban general hospital Free

Abstract

Mobile drug-resistance genes with identical nucleic acid sequences carried by multidrug-resistant strains that cause community-acquired infections are becomingly increasingly dispersed worldwide. Over a 2-year period, we analysed Gram-negative bacterial (GNB) pathogens from the blood of inpatients at an urban public hospital to determine what proportion of these isolates carried such globally dispersed drug-resistance genes. Of 376 GNB isolates, 167 (44 %) were , 50 (13 %) were , 25 (7 %) were , 25 (7 %) were and 20 (5 %) were ; the remainder (24 %) comprised 26 different GNB species. Among isolates, class 1 integrons were detected in 64 (38 %). The most common integron gene cassette configuration was , found in 30 (25 %) of 119 drug-resistant isolates and in one isolate of . Extended-spectrum β-lactamase (ESBL) genes were found in 16 isolates (10 %). These genes with identical sequences were found in nearly 40 % of bloodstream isolates in the study hospital, as well as in a variety of bacterial species from clinical and non-clinical sources worldwide. Thus, a substantial proportion of bloodstream infections among hospitalized patients were caused by strains carrying drug-resistance genes that are dispersed globally in a wide variety of bacterial species.

  • Received:
  • Accepted:
  • Published Online:
© 2012 SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.041970-0
2012-07-01
2024-04-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/7/968.html?itemId=/content/journal/jmm/10.1099/jmm.0.041970-0&mimeType=html&fmt=ahah

References

  1. Ajiboye R. M., Solberg O. D., Lee B. M., Raphael E., Debroy C., Riley L. W. 2009; Global spread of mobile antimicrobial drug resistance determinants in human and animal Escherichia coli and Salmonella strains causing community-acquired infections. Clin Infect Dis 49:365–371[PubMed] [CrossRef]
     [Google Scholar]
  2. CLSI 2011; Performance Standards for Antimicrobial Susceptibility Testing, 21st Informational Supplement. M100-S21. Wayne, PA: Clinical and Laboratory Standards Institute;
  3. Cocchi S., Grasselli E., Gutacker M., Benagli C., Convert M., Piffaretti J. C. 2007; Distribution and characterization of integrons in Escherichia coli strains of animal and human origin. FEMS Immunol Med Microbiol 50:126–132[PubMed] [CrossRef]
     [Google Scholar]
  4. Coque T. M., Novais A., Carattoli A., Poirel L., Pitout J., Peixe L., Baquero F., Cantón R., Nordmann P. 2008; Dissemination of clonally related Escherichia coli strains expressing extended-spectrum β-lactamase CTX-M-15. Emerg Infect Dis 14:195–200[PubMed] [CrossRef]
     [Google Scholar]
  5. Dallenne C., Da Costa A., Decré D., Favier C., Arlet G. 2010; Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae . J Antimicrob Chemother 65:490–495[PubMed] [CrossRef]
     [Google Scholar]
  6. Dias R. C., Marangoni D. V., Smith S. P., Alves E. M., Pellegrino F. L., Riley L. W., Moreira B. M. 2009; Clonal composition of Escherichia coli causing community-acquired urinary tract infections in the State of Rio de Janeiro, Brazil. Microb Drug Resist 15:303–308[PubMed] [CrossRef]
     [Google Scholar]
  7. Enne V. I., Livermore D. M., Stephens P., Hall L. M. 2001; Persistence of sulphonamide resistance in Escherichia coli in the UK despite national prescribing restriction. Lancet 357:1325–1328[PubMed] [CrossRef]
     [Google Scholar]
  8. Friedman N. D., Kaye K. S., Stout J. E., McGarry S. A., Trivette S. L., Briggs J. P., Lamm W., Clark C., MacFarquhar J. other authors 2002; Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 137:791–797[PubMed] [CrossRef]
     [Google Scholar]
  9. Johnson L., Sabel A., Burman W. J., Everhart R. M., Rome M., MacKenzie T. D., Rozwadowski J., Mehler P. S., Price C. S. 2008; Emergence of fluoroquinolone resistance in outpatient urinary Escherichia coli isolates. Am J Med 121:876–884[PubMed] [CrossRef]
     [Google Scholar]
  10. Johnson J. R., Menard M., Johnston B., Kuskowski M. A., Nichol K., Zhanel G. G. 2009; Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004. Antimicrob Agents Chemother 53:2733–2739[PubMed] [CrossRef]
     [Google Scholar]
  11. Johnson J. R., Johnston B., Clabots C., Kuskowski M. A., Castanheira M. 2010; Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 51:286–294[PubMed] [CrossRef]
     [Google Scholar]
  12. Kumarasamy K. K., Toleman M. A., Walsh T. R., Bagaria J., Butt F., Balakrishnan R., Chaudhary U., Doumith M., Giske C. G. other authors 2010; Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10:597–602[PubMed] [CrossRef]
     [Google Scholar]
  13. Lévesque C., Piché L., Larose C., Roy P. H. 1995; PCR mapping of integrons reveals several novel combinations of resistance genes. Antimicrob Agents Chemother 39:185–191[PubMed] [CrossRef]
     [Google Scholar]
  14. Li J., Ma Y., Hu C., Jin S., Zhang Q., Ding H., Ran L., Cui S. 2010; Dissemination of cefotaxime-M-producing Escherichia coli isolates in poultry farms, but not swine farms, in China. Foodborne Pathog Dis 7:1387–1392[PubMed] [CrossRef]
     [Google Scholar]
  15. Manges A. R., Johnson J. R., Foxman B., O’Bryan T. T., Fullerton K. E., Riley L. W. 2001; Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group. N Engl J Med 345:1007–1013[PubMed] [CrossRef]
     [Google Scholar]
  16. Manges A. R., Natarajan P., Solberg O. D., Dietrich P. S., Riley L. W. 2006; The changing prevalence of drug-resistant Escherichia coli clonal groups in a community: evidence for community outbreaks of urinary tract infections. Epidemiol Infect 134:425–431[PubMed] [CrossRef]
     [Google Scholar]
  17. Márquez C., Labbate M., Raymondo C., Fernández J., Gestal A. M., Holley M., Borthagaray G., Stokes H. W. 2008; Urinary tract infections in a South American population: dynamic spread of class 1 integrons and multidrug resistance by homologous and site-specific recombination. J Clin Microbiol 46:3417–3425[PubMed] [CrossRef]
     [Google Scholar]
  18. Martinez-Freijo P., Fluit A. C., Schmitz F. J., Grek V. S., Verhoef J., Jones M. E. 1998; Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds. J Antimicrob Chemother 42:689–696[PubMed] [CrossRef]
     [Google Scholar]
  19. Olesen B., Kolmos H. J., Orskov F., Orskov I. 1994; Cluster of multiresistant Escherichia coli O78 : H10 in Greater Copenhagen. Scand J Infect Dis 26:406–410[PubMed] [CrossRef]
     [Google Scholar]
  20. Peirano G., Pitout J. D. 2010; Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25 : H4. Int J Antimicrob Agents 35:316–321[PubMed] [CrossRef]
     [Google Scholar]
  21. Peleg A. Y., Hooper D. C. 2010; Hospital-acquired infections due to Gram-negative bacteria. N Engl J Med 362:1804–1813[PubMed] [CrossRef]
     [Google Scholar]
  22. Pitout J. D., Laupland K. B. 2008; Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8:159–166[PubMed] [CrossRef]
     [Google Scholar]
  23. Pitout J. D., Nordmann P., Laupland K. B., Poirel L. 2005; Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 56:52–59[PubMed] [CrossRef]
     [Google Scholar]
  24. Shibata N., Kurokawa H., Doi Y., Yagi T., Yamane K., Wachino J., Suzuki S., Kimura K., Ishikawa S. other authors 2006; PCR classification of CTX-M-type β-lactamase genes identified in clinically isolated Gram-negative bacilli in Japan. Antimicrob Agents Chemother 50:791–795[PubMed] [CrossRef]
     [Google Scholar]
  25. Smith S. P., Manges A. R., Riley L. W. 2008; Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition. Clin Infect Dis 46:689–695[PubMed] [CrossRef]
     [Google Scholar]
  26. Solberg O. D., Ajiboye R. M., Riley L. W. 2006; Origin of class 1 and 2 integrons and gene cassettes in a population-based sample of uropathogenic Escherichia coli . J Clin Microbiol 44:1347–1351[PubMed] [CrossRef]
     [Google Scholar]
  27. Suzuki S., Shibata N., Yamane K., Wachino J., Ito K., Arakawa Y. 2009; Change in the prevalence of extended-spectrum-β-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 63:72–79[PubMed] [CrossRef]
     [Google Scholar]
  28. Tartof S. Y., Solberg O. D., Riley L. W. 2007; Genotypic analyses of uropathogenic Escherichia coli based on fimH single nucleotide polymorphisms (SNPs). J Med Microbiol 56:1363–1369[PubMed] [CrossRef]
     [Google Scholar]
  29. Vincent C., Boerlin P., Daignault D., Dozois C. M., Dutil L., Galanakis C., Reid-Smith R. J., Tellier P. P., Tellis P. A. other authors 2010; Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis 16:88–95[PubMed] [CrossRef]
     [Google Scholar]
  30. Vinué L., Sáenz Y., Somalo S., Escudero E., Moreno M. A., Ruiz-Larrea F., Torres C. 2008; Prevalence and diversity of integrons and associated resistance genes in faecal Escherichia coli isolates of healthy humans in Spain. J Antimicrob Chemother 62:934–937[PubMed] [CrossRef]
     [Google Scholar]
  31. Woerther P. L., Angebault C., Lescat M., Ruppé E., Skurnik D., Mniai A. E., Clermont O., Jacquier H., Costa A. D. other authors 2010; Emergence and dissemination of extended-spectrum β-lactamase-producing Escherichia coli in the community: lessons from the study of a remote and controlled population. J Infect Dis 202:515–523[PubMed] [CrossRef]
     [Google Scholar]
  32. Yu H. S., Lee J. C., Kang H. Y., Jeong Y. S., Lee E. Y., Choi C. H., Tae S. H., Lee Y. C., Seol S. Y., Cho D. T. 2004; Prevalence of dfr genes associated with integrons and dissemination of dfrA17 among urinary isolates of Escherichia coli in Korea. J Antimicrob Chemother 53:445–450[PubMed] [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.041970-0
Loading
Globally dispersed mobile drug-resistance genes in Gram-negative bacterial isolates from patients with bloodstream infections in a US urban general hospital
J. Med. Microbiol. 61, 968 (2012); https://doi.org/10.1099/jmm.0.041970-0
/content/journal/jmm/10.1099/jmm.0.041970-0
/content/journal/jmm/10.1099/jmm.0.041970-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error